On behalf of the nation’s radiation oncologists, the American Society for Radiation Oncology expressed strong support for Wednesday’s Senate introduction of bipartisan federal legislation that would rein in restrictive prior authorization practices delaying patient access to critical cancer treatments.
Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.
